Primary care update on kidney and bladder cancer: a urologic perspective.
The past decade has witnessed many substantive changes in the approach to the diagnosis and treatment of both kidney and bladder cancer. In part, this is based on changes in the understanding of their carcinogenesis and pathogenesis, an appreciation of new concepts in their classification, and the incorporation of new technologies that have emerged. This article reviews advances and updates changes that have been made in the understanding of and approaches to these malignancies from the perspective of their urologic assessment and management while in the context of primary care issues.
Droller
Michael J
MJ
Department of Urology, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1272, New York, NY 10029-6574, USA. sarah.mcdermott@mountsinai.org
D002277:Carcinoma / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D011320:Primary Health Care; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000628:therapy